ANIXA BIOSCIENCES, INC. Selling, General and Administrative Expense
ANIXA BIOSCIENCES, INC. (ANIX) reported Selling, General and Administrative Expense of $1.44 million for the 3-month period ending 2020-04-30, per its 10-Q filed 2020-06-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2020-06-09
- ANIXA BIOSCIENCES, INC. selling, general and administrative expense for the quarter ending 2020-04-30 was $1.44M, a 12.43% increase year-over-year.
- ANIXA BIOSCIENCES, INC. selling, general and administrative expense for the quarter ending 2020-01-31 was $1.14M, a 44.87% decline year-over-year.
- ANIXA BIOSCIENCES, INC. selling, general and administrative expense for the quarter ending 2019-10-31 was $1.26M, a 45.55% decline year-over-year.
- ANIXA BIOSCIENCES, INC. selling, general and administrative expense for the quarter ending 2019-07-31 was $1.06M, a 60.91% decline year-over-year.
- ANIXA BIOSCIENCES, INC. selling, general and administrative expense for fiscal 2019 was $5.66M, a 18.07% decline from fiscal 2018.
- ANIXA BIOSCIENCES, INC. selling, general and administrative expense for fiscal 2018 was $6.91M, a 56.71% increase from fiscal 2017.
- ANIXA BIOSCIENCES, INC. selling, general and administrative expense for fiscal 2017 was $4.41M, a 62.77% increase from fiscal 2016.
- ANIXA BIOSCIENCES, INC. selling, general and administrative expense for fiscal 2016 was $2.71M, a 50.86% decline from fiscal 2015.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-04-30 | $1.44M 10-Q · filed 2020-06-09 | $2.58M 10-Q · filed 2020-06-09 | $3.84M derived: sum of 3 quarters · filed 2020-06-09 | $4.90M derived: sum of 4 quarters · filed 2020-06-09 | ||||
| 2020-01-31 | $1.14M 10-Q · filed 2020-03-09 | $2.40M derived: sum of 2 quarters · filed 2020-03-09 | $3.45M derived: sum of 3 quarters · filed 2020-03-09 | $4.74M derived: sum of 4 quarters · filed 2020-06-09 | ||||
| 2019-10-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2020-01-09 | $2.31M derived: sum of 2 quarters · filed 2020-01-09 | $3.60M derived: sum of 3 quarters · filed 2020-06-09 | $5.66M 10-K · filed 2020-01-09 | ||||
| 2019-07-31 | $1.06M 10-Q · filed 2019-09-06 | $2.34M derived: sum of 2 quarters · filed 2020-06-09 | $4.41M 10-Q · filed 2019-09-06 | $6.71M derived: sum of 4 quarters · filed 2020-06-09 | ||||
| 2019-04-30 | $1.28M 10-Q · filed 2020-06-09 | $3.35M 10-Q · filed 2020-06-09 | $5.66M derived: sum of 3 quarters · filed 2020-06-09 | $8.36M derived: sum of 4 quarters · filed 2020-06-09 | ||||
| 2019-01-31 | $2.07M 10-Q · filed 2020-03-09 | $4.38M derived: sum of 2 quarters · filed 2020-03-09 | $7.08M derived: sum of 3 quarters · filed 2020-03-09 | $7.99M derived: sum of 4 quarters · filed 2020-03-09 | ||||
| 2018-10-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2020-01-09 | $5.01M derived: sum of 2 quarters · filed 2020-01-09 | $5.92M derived: sum of 3 quarters · filed 2020-01-09 | $6.91M 10-K · filed 2020-01-09 | ||||
| 2018-07-31 | $2.70M 10-Q · filed 2019-09-06 | $3.61M derived: sum of 2 quarters · filed 2019-09-06 | $4.60M 10-Q · filed 2019-09-06 | $5.95M derived: sum of 4 quarters · filed 2019-09-06 | ||||
| 2018-04-30 | $908.77K 10-Q · filed 2019-06-12 | $1.90M 10-Q · filed 2019-06-12 | $3.24M derived: sum of 3 quarters · filed 2019-06-12 | $4.75M derived: sum of 4 quarters · filed 2019-06-12 | ||||
| 2018-01-31 | $990.04K 10-Q · filed 2019-03-13 | $2.33M derived: sum of 2 quarters · filed 2019-03-13 | $3.84M derived: sum of 3 quarters · filed 2019-03-13 | $4.54M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-10-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-11 | $2.85M derived: sum of 2 quarters · filed 2019-01-11 | $3.55M derived: sum of 3 quarters · filed 2019-01-11 | $4.41M 10-K · filed 2019-01-11 | ||||
| 2017-07-31 | $1.51M 10-Q · filed 2018-09-07 | $1.51M 10-Q · filed 2017-09-08 | $2.21M derived: sum of 2 quarters · filed 2018-09-07 | $3.07M 10-Q · filed 2018-09-07 | $3.61M derived: sum of 4 quarters · filed 2018-09-07 | |||
| 2017-04-30 | $699.35K 10-Q · filed 2018-06-11 | $1.56M 10-Q · filed 2018-06-11 | $2.11M derived: sum of 3 quarters · filed 2018-06-11 | $2.74M derived: sum of 4 quarters · filed 2018-06-11 | ||||
| 2017-01-31 | $859.88K 10-Q · filed 2018-03-09 | $1.41M derived: sum of 2 quarters · filed 2018-03-09 | $2.04M derived: sum of 3 quarters · filed 2018-03-09 | $2.70M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-10-31 | $546.51K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-09 | $1.18M derived: sum of 2 quarters · filed 2018-01-09 | $1.84M derived: sum of 3 quarters · filed 2018-01-09 | $2.71M 10-K · filed 2018-01-09 | ||||
| 2016-07-31 | $631.23K 10-Q · filed 2017-09-08 | $923.29K 10-Q · filed 2016-08-19 | $1.29M derived: sum of 2 quarters · filed 2017-09-08 | $2.16M 10-Q · filed 2017-09-08 | $3.31M 10-Q · filed 2016-08-19 | $2.53M derived: sum of 4 quarters · filed 2017-09-08 | ||
| 2016-04-30 | $658.95K 10-Q · filed 2017-05-26 | $1.05M 10-Q · filed 2016-05-20 | $1.53M 10-Q · filed 2017-05-26 | $2.38M 10-Q · filed 2016-05-20 | $1.89M derived: sum of 3 quarters · filed 2017-05-26 | $3.32M derived: sum of 4 quarters · filed 2017-05-26 | ||
| 2016-01-31 | $873.42K 10-Q · filed 2017-03-16 | $1.33M 10-Q · filed 2016-02-19 | $1.24M derived: sum of 2 quarters · filed 2017-03-16 | $2.66M derived: sum of 3 quarters · filed 2017-03-16 | $4.61M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-10-31 | $362.07K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-08 | $1.78M derived: sum of 2 quarters · filed 2016-12-08 | $3.74M derived: sum of 3 quarters · filed 2016-12-08 | $5.51M 10-K · filed 2016-12-08 | $6.23M 10-K · filed 2015-12-23 | |||
| 2015-07-31 | $1.42M 10-Q · filed 2016-08-19 | $3.38M derived: sum of 2 quarters · filed 2016-08-19 | $5.15M 10-Q · filed 2016-08-19 | $6.75M derived: sum of 4 quarters · filed 2016-08-19 | ||||
| 2015-04-30 | $1.96M 10-Q · filed 2016-05-20 | $3.73M 10-Q · filed 2016-05-20 | $5.33M derived: sum of 3 quarters · filed 2016-05-20 | $6.43M derived: sum of 4 quarters · filed 2016-05-20 | ||||
| 2015-01-31 | $1.77M 10-Q · filed 2016-02-19 | $3.38M derived: sum of 2 quarters · filed 2016-02-19 | $4.48M derived: sum of 3 quarters · filed 2016-02-19 | $6.32M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-10-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | $2.70M derived: sum of 2 quarters · filed 2015-12-23 | $4.55M derived: sum of 3 quarters · filed 2015-12-23 | $6.41M 10-K · filed 2015-12-23 | ||||
| 2014-07-31 | $1.10M 10-Q · filed 2015-08-18 | $2.95M derived: sum of 2 quarters · filed 2015-08-18 | $4.81M 10-Q · filed 2015-08-18 | $6.68M derived: sum of 4 quarters · filed 2015-08-18 | ||||
| 2014-04-30 | $1.84M 10-Q · filed 2015-05-22 | $3.70M 10-Q · filed 2015-05-22 | $5.57M derived: sum of 3 quarters · filed 2015-05-22 | $7.78M derived: sum of 4 quarters · filed 2015-05-22 | ||||
| 2014-01-31 | $1.86M 10-Q · filed 2015-03-09 | $1.93M 10-Q · filed 2014-03-17 | $3.73M derived: sum of 2 quarters · filed 2015-03-09 | $5.93M derived: sum of 3 quarters · filed 2015-03-09 | $7.78M derived: sum of 4 quarters · filed 2015-03-09 | |||
| 2013-10-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-29 | $4.07M derived: sum of 2 quarters · filed 2015-01-29 | $5.92M derived: sum of 3 quarters · filed 2015-01-29 | $7.99M 10-K · filed 2015-01-29 | ||||
| 2013-07-31 | $2.20M 10-Q · filed 2014-09-15 | $2.22M 10-Q/A · filed 2013-09-20 | $4.05M derived: sum of 2 quarters · filed 2014-09-15 | $6.12M 10-Q · filed 2014-09-15 | $6.12M 10-Q/A · filed 2013-09-20 | $7.34M derived: sum of 4 quarters · filed 2014-09-15 | ||
| 2013-04-30 | $1.84M 10-Q · filed 2014-06-16 | $1.85M 10-Q/A · filed 2013-06-19 | $3.92M 10-Q · filed 2014-06-16 | $3.90M 10-Q/A · filed 2013-06-19 | $5.14M derived: sum of 3 quarters · filed 2014-06-16 | $5.57M derived: sum of 4 quarters · filed 2014-06-16 | ||
| 2013-01-31 | $2.07M 10-Q · filed 2014-03-17 | $2.05M 10-Q/A · filed 2013-03-25 | $3.29M derived: sum of 2 quarters · filed 2014-03-17 | $3.73M derived: sum of 3 quarters · filed 2014-03-17 | $4.25M derived: sum of 4 quarters · filed 2014-03-17 | |||
| 2012-10-31 | $1.22M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2014-01-17 | $1.66M derived: sum of 2 quarters · filed 2014-01-17 | $2.18M derived: sum of 3 quarters · filed 2014-01-17 | $2.86M 10-K/A · filed 2014-01-17 | $2.87M 10-K · filed 2013-01-29 | |||
| 2012-07-31 | $433.68K 10-Q/A · filed 2013-09-20 | $955.24K derived: sum of 2 quarters · filed 2013-09-20 | $1.64M 10-Q/A · filed 2013-09-20 | $2.36M derived: sum of 4 quarters · filed 2013-09-20 | ||||
| 2012-04-30 | $521.56K 10-Q/A · filed 2013-06-19 | $1.21M 10-Q/A · filed 2013-06-19 | $1.93M derived: sum of 3 quarters · filed 2013-06-19 | $2.70M derived: sum of 4 quarters · filed 2013-06-19 | ||||
| 2012-01-31 | $686.03K 10-Q/A · filed 2013-03-25 | $1.40M derived: sum of 2 quarters · filed 2013-03-25 | $2.18M derived: sum of 3 quarters · filed 2013-03-25 | $2.80M derived: sum of 4 quarters · filed 2013-03-25 | ||||
| 2011-10-31 | $718.87K derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | $1.49M derived: sum of 2 quarters · filed 2013-01-29 | $2.11M derived: sum of 3 quarters · filed 2013-01-29 | $2.87M 10-K · filed 2013-01-29 | ||||
| 2011-07-31 | $774.75K 10-Q · filed 2012-09-14 | $1.39M derived: sum of 2 quarters · filed 2012-09-14 | $2.15M 10-Q · filed 2012-09-14 | $2.80M derived: sum of 4 quarters · filed 2012-09-14 | ||||
| 2011-04-30 | $618.01K 10-Q · filed 2012-06-14 | $1.38M 10-Q · filed 2012-06-14 | $2.02M derived: sum of 3 quarters · filed 2012-06-14 | $2.64M derived: sum of 4 quarters · filed 2012-06-14 | ||||
| 2011-01-31 | $760.98K 10-Q · filed 2012-03-16 | $1.40M derived: sum of 2 quarters · filed 2012-03-16 | $2.02M derived: sum of 3 quarters · filed 2012-03-16 | |||||
| 2010-10-31 | $643.05K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-01-30 | $1.26M derived: sum of 2 quarters · filed 2012-01-30 | $2.89M 10-K · filed 2012-01-30 | |||||
| 2010-07-31 | $620.97K 10-Q/A · filed 2011-10-14 | $2.25M 10-Q/A · filed 2011-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |